GOLDSTEIN DOV A MD 内部人交易：近期 SEC Form 4 交易
过去 18 个月，GOLDSTEIN DOV A MD（CIK 1120478）在 2 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-04-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-04-24 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 买入 | 3,542 | $15,514 |
| 2026-03-03 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 买入 | 3,542 | $15,514 |
| 2026-02-03 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 买入 | 3,541 | $15,510 |
| 2026-01-21 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 买入 | 3,542 | $15,514 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 买入 | 27,000 | $226,530 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 卖出 | 8,974 | $165,391 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 卖出 | 4,440 | $86,358 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 卖出 | 11,663 | $239,558 |
| 2026-01-15 | BioAge Labs, Inc. (BIOA) | Chief Financial Officer | 卖出 | 1,923 | $40,537 |
| 2025-08-19 | Coya Therapeutics, Inc. (COYA) | 董事 | 买入 | 17,557 | $19,137 |
来源：SEC Form 4 申报文件 · 截至 2026-04-24